Carregant...

Benznidazole Treatment following Acute Trypanosoma cruzi Infection Triggers CD8(+) T-Cell Expansion and Promotes Resistance to Reinfection

Many studies have shed light on the mechanisms underlying both immunoprotection and immune dysregulation arising after Trypanosoma cruzi infection. However, little is known about the impact of benznidazole (N-benzyl-2-nitroimidazole acetamide), the drug available for clinical treatment of the infect...

Descripció completa

Guardat en:
Dades bibliogràfiques
Autors principals: Olivieri, Bianca Perdigão, Cotta-de-Almeida, Vinícius, Araújo-Jorge, Tania
Format: Artigo
Idioma:Inglês
Publicat: American Society for Microbiology 2002
Matèries:
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC132750/
https://ncbi.nlm.nih.gov/pubmed/12435678
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1128/AAC.46.12.3790-3796.2002
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!